Dudediligence.

Tenax Therapeutics, Inc

TENXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

31.9M

on 2026-06-30, from 1.96M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

10M20M30MMar2024JunSepDecMar2025JunSepDecMar2026Jun

Newest

$300.0M

S-3 of 2026-03-24. None sold under it to 2026-10-05. S-3 ↗

1 of its filings are not read yet.

Warrants

7.51M

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $6.91. 10-Q ↗

Cash

10.3 quarters

$118.0M on 2026-06-30 ÷ $11.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-03-04Private placement incl. 3.76M pre-funded4,139,072not read$25.0M8-K ↗